GREY:ATBPF - Post by User
Post by
MrMugsyon May 04, 2022 5:30pm
![](https://assets.stockhouse.com/kentico-cms/0341-00/images/Sprite.svg#id_Post_Views_Icon)
206 Views
Post# 34656684
latest precedent setting for fast-track ... Alzheimer's
latest precedent setting for fast-track ... Alzheimer'sWe already discussed the precedent setting for opioid replacement fast-tracking (Heron Therapeutics).
This is a few years too early for our needs - but - here's one to reference on safety data for Alzheimer's fast-tracking ... when we get there.
https://www.dallasnews.com/business/health-care/2022/05/02/vaxxinity-vaccine-to-treat-alzheimers-wins-fda-fast-track-designation/ They're still going after amyloid beta and that didn't serve Biogen all that well (CEO is leaving at Biogen on the drug screw-up). There was a $20B jump after FDA approval and then ~$28B drop after that.
But, no brain swelling in Vaxxinity's version ... a good thing for them.